Psilocybin molecule:

Image from PubChem

Psilocybin Clinical Trials


Psilocybin vs. escitalopram for major depressive disorder: comparative mechanisms


To see complete record on www.clinicaltrialsregister.eu, please visit this link

Id: 2017-000219-18

Organisation Name: Imperial College London

Start Date: 2018-04-09

Completion Date: Ongoing

Brief Summary: How effective is a single dose of psilocybin for major depressive disorder against an an active gold-standard medical treatment (6-weeks of escitalopram)?

Country: United Kingdom



Total execution time in seconds: 0.050205945968628